Author:
Abdulkareem Alaa Abdulrazzaq,Ghalib Hawar Ali,Rashaan Mezjda Ismail
Abstract
Abstract
Background
Since breast cancer (BC) has the best chance of being effectively treated when it is tiny and has not spread, encouraging early disease detection remains a fundamental goal in improving prognosis.
Objective
To quantify the magnitude of the delay in BC presentation as well as the contributing factors related to this delay.
Patients and methods
Data was collected at the Breast Diseases Treatment Clinic, Shar Teaching Hospital, Sulaimani, Iraq from January 2017 to December 2021 of 429 patients. A validated questionnaire was distributed to women about their demographics, health, and general awareness of the disease. The patient delay was calculated by collecting information on when they initially began experiencing symptoms and when they saw a doctor. We also gleaned information about the tumour’s clinicopathological features from the patient’s medical records.
Results
The participants’ ages ranged from 24 to 85 years, with a mean of 49.6 ± 11. Most women were middle-aged (53.8%), from urban areas (80.2%), illiterate (41.7%), married (86.5%), housewives (79.0%), given birth to > 4 children (34%), practised breastfeeding (78.8%), and non-smokers (91.4%). Regarding patients’ health behaviours, there were highly significant correlations between early and late presentation (p < 0.001). Concerning the patient’s awareness of BC symptoms, there were highly significant correlations between early and late presentation (p < 0.001). In addition, the late presentation was strongly correlated with bilateral BC, lymph node involvement, inflammatory BC, grade III BC, and T4 status.
Conclusions
Our findings shed light on possible causes of late presentation and identified those at risk of delayed consultation. Our communities need to be educated about BC, and encouraging them for early detection decreases the incidence of advanced BC.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Reproductive Medicine,General Medicine
Reference39 articles.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209–49.
2. Hashim HT, Ramadhan MA, Theban KM, Bchara J, El-Abed-El-Rassoul A, Shah J. Assessment of breast cancer risk among iraqi women in 2019. BMC Womens Health. 2021;21:1–9.
3. Majid RA, Mohammed HA, Saeed HM, Safar BM, Rashid RM, Hughson MD. Breast cancer in kurdish women of northern Iraq: incidence, clinical stage, and case-control analysis of parity and family risk. BMC Womens Health. 2009;9:1–6.
4. Porter P. Westernizing women’s risks? Breast cancer in lower-income countries. N Engl J Med. 2008;358:213–6.
5. McCoy CB, Pereyra M, Metsch LR, Collado-Mesa F, Messiah SE, Sears S. A community-based breast cancer screening program for medically underserved women: its effect on disease stage at diagnosis and on the hazard of death. Revista Panam de Salud Pública. 2004;15:160–7.